DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Ieko M, Yoshida M, Naito S. et al.
Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation.
Int J Hematol 2010;
91 (05) 776-783
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.